On July 18, 2026, Benovas Medical Devices Joint Stock Company (BMD) participated in the 2026 Annual Scientific Conference organized by the Medical Biochemistry Association of the Central Highlands and Central Vietnam Provinces. The event provided an opportunity for BMD to showcase its medical device solutions, strengthen connections with healthcare experts, hospitals, and medical institutions, and expand collaboration opportunities, contributing to the advancement of laboratory medicine and diagnostics in Vietnam.
Held annually, the conference is one of the region’s leading professional forums in the fields of medical biochemistry and laboratory diagnostics. It brought together experts, physicians, laboratory technicians, and representatives from hospitals, diagnostic centers, and healthcare institutions across Central Vietnam and the Central Highlands to discuss the latest technological advancements, scientific innovations, and practical experiences in clinical laboratory practice.
As the healthcare industry continues to accelerate the adoption of advanced technologies to improve diagnostic accuracy and treatment outcomes, the conference served not only as an academic platform but also as an important venue for medical device companies to introduce innovative solutions, engage with healthcare professionals, and explore new partnership opportunities.
The conference attracted a large number of healthcare professionals and industry experts.
At the event, BMD presented a range of medical devices and healthcare solutions designed to support laboratory testing and patient care, addressing the evolving needs of healthcare providers. The company’s exhibition booth attracted significant interest from attendees, enabling the BMD team to engage directly with physicians, specialists, and customers to discuss product specifications, clinical applications, and emerging requirements in today’s laboratory environment.
Through its participation, BMD not only introduced its manufacturing capabilities and comprehensive product portfolio but also gathered valuable feedback from medical professionals. These insights will support the company’s continuous efforts to enhance its products, improve quality, and better meet the increasingly diverse demands of the healthcare market.
BMD’s exhibition booth attracted considerable attention from conference participants.
Participating in the conference also strengthened BMD’s brand presence within the healthcare community while expanding its network with hospitals, diagnostic laboratories, and partners throughout Central Vietnam and the Central Highlands. The region represents a promising market and plays an important role in BMD’s strategy to expand its distribution network and market presence.
Beyond its business development objectives, BMD views participation in scientific conferences as an important opportunity to stay abreast of technological trends, better understand the practical needs of the healthcare sector, and foster meaningful dialogue with leading medical experts. The professional relationships established through these events lay the foundation for long-term collaborations that drive innovation and enhance the quality of medical device solutions.
As a medical device manufacturer, BMD continues to invest in manufacturing capabilities, research, and product development to deliver high-quality products that meet the increasingly stringent requirements of both domestic and international markets. The company’s active participation in scientific conferences, exhibitions, and industry forums remains a key strategy for expanding its professional network, keeping pace with emerging technologies, and reinforcing its position within the medical device industry.
Through its participation in the 2026 Annual Scientific Conference, BMD once again reaffirmed its commitment to sustainable growth through innovation, collaboration, and partnership with the healthcare community. Looking ahead, the company will continue to strengthen professional engagement, introduce advanced medical device solutions, and expand cooperation with domestic and international partners, contributing to the continuous improvement of healthcare services and patient care.
